An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: the DUBHE randomized clinical trial

Mu Xian(Beijing Tongren Hospital), Luo Zhang(Hebei Medical University), Yan Jiang(Qingdao University), Shaoqing Yu(Intelligent Health (United Kingdom)), Yan Xie(Chinese Academy of Medical Sciences & Peking Union Medical College), Lizhong Su(Beihang University), Lijia Wan(Yangtze University), Yucheng Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Xianyang Luo(First Affiliated Hospital of Xiamen University), Feng Lan(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinmei Xue(Shanxi Medical University), Guoping Yang(Central South University), Guolin Tan(Central South University), Qinna Zhang(Shanxi Medical University), Xin Wei(Hainan General Hospital), Hongyan Fang(First People's Hospital of Chongqing), Bo Chen(Bioscience (China)), Jing Ye(Nanchang University), Jianjun Chen(Union Hospital), Feng Liu(Sichuan University), Qin Li(Yangtze University), Shixi Liu(Crown College), Lin Wang(Inner Mongolia Agricultural University), Guoqing Zhao(Jilin University), Yu Zhang(Hefei University of Technology), Hongyue Yan(Bioscience (China)), Yu Xu(Fujian Medical University), Shen Shen(Capital Medical University), Xicheng Song(Yuhuangding Hospital), Luyun Jiang(Chengdu University of Traditional Chinese Medicine), Bing Yan(Beijing Tongren Hospital), Shenhong Qu(The People's Hospital of Guangxi Zhuang Autonomous Region), Chengshuo Wang(Chinese Academy of Sciences)
Nature Communications
September 29, 2025
Cited by 5


Related Papers